India's Bharat Biotech has said it followed a step-by-step approach for regulatory approval and supply contract for its COVID-19 vaccine Covaxin in Brazil during the eight-month-long process. "We haven't received any advance payments nor supplied vaccines to Brazil," it added. Its statement came after Brazil suspended a ₹2,400-crore deal to buy two crore Covaxin doses amid corruption allegations.